Somalogic Inc - Asset Resilience Ratio
Somalogic Inc (SLGC) has an Asset Resilience Ratio of 26.23% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check SLGC strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2022)
This chart shows how Somalogic Inc's Asset Resilience Ratio has changed over time. See SLGC net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Somalogic Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SLGC company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $148.24 Million | 26.23% |
| Total Liquid Assets | $148.24 Million | 26.23% |
Asset Resilience Insights
- Very High Liquidity: Somalogic Inc maintains exceptional liquid asset reserves at 26.23% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Somalogic Inc Industry Peers by Asset Resilience Ratio
Compare Somalogic Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INVENTURUS KNOWLEDGE SO L
NSE:IKS |
Health Information Services | 0.39% |
|
Waystar Holding Corp. Common Stock
NASDAQ:WAY |
Health Information Services | 2.13% |
|
DocCheck AG
XETRA:AJ91 |
Health Information Services | 7.30% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 32.70% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
|
Oneview Healthcare Plc
AU:ONE |
Health Information Services | 29.71% |
Annual Asset Resilience Ratio for Somalogic Inc (2019–2022)
The table below shows the annual Asset Resilience Ratio data for Somalogic Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 18.19% | $117.76 Million | $647.37 Million | -12.71pp |
| 2021-12-31 | 30.90% | $218.22 Million | $706.10 Million | +14.41pp |
| 2020-12-31 | 16.49% | $39.95 Million | $242.29 Million | -27.71pp |
| 2019-12-31 | 44.20% | $31.50 Million | $71.26 Million | -- |
About Somalogic Inc
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in … Read more